Skip to main content
FDA commissioner: Patients' perspectives should be heard
8/14/2018

At a National Health Council briefing, FDA Commissioner Scott Gottlieb discussed the importance of patients' perspectives for drug development, reviews and prescribing practices. Gottlieb shared his experience of being diagnosed with stage 1 Hodgkin lymphoma in 2006 and how daunting it was even with his physician saying he had more than a 90% chance of a complete cure.

Full Story: